| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. (OTLK) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. OTLK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.46M | $5.46M | +24.03M | |
| CEO | 800.0K | $1.26M | - | |
| Dir | 423.7K | $669.4K | +400.0K | |
| Dir | 286.7K | $453.0K | - | |
| Dir | 117.3K | $185.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2017 | Bahrt Kenneth | Chief Medical Officer | Sell | 26,165 | $1.13 | $29,566.45 | -32.3% | |
| Dec 22, 2017 | McAndrew Stephen J | SVP Bus. Strat. &Dev. | Sell | 15,705 | $1.13 | $17,746.65 | -23.6% | |
| Dec 22, 2017 | Kenyon Lawrence A | CFO And Secretary | Sell | 26,165 | $1.13 | $29,566.45 | -28.0% | |
| Dec 19, 2017 | Mohan Pankaj | President &CEO | Sell | 104,131 | $1.15 | $119,325.03 | -0.7% | |
| Dec 19, 2017 | Yamashita Elizabeth A. | VP, Regulatory Affairs | Sell | 7,660 | $1.15 | $8,777.67 | -4.4% | |
| Nov 23, 2016 | Griffith Donald J. | Director | Sell | 1 | $3.75 | $3.75 | - | |
| Nov 11, 2016 | McAndrew Stephen J | SVP Bus. Strat. &Dev. | Sale+OE | 21,367 | $3.75 | $80,126.25 | -36.9% | |
| Nov 11, 2016 | Gangloff Scott A. | SVP, Development &Mfrg | Sale+OE | 37,369 | $3.75 | $140,133.75 | -32.2% | |
| May 13, 2016 | Bahrt Kenneth | Chief Medical Officer | Buy | 2,000 | $0.00 | - | New |